Erik Jakobsen

机构：Odense University Hospital, Nord University · ORCID：0000-0002-0052-7705

发表论文 261 篇 · 总被引 18568 次 · h-index 47

代表论文

• Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial (2022 · Nature Medicine · 被引 89)
• Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial (2022 · Journal of Clinical Oncology · 被引 84)
• European Respiratory Society guideline on various aspects of quality in lung cancer care (2022 · European Respiratory Journal · 被引 30)
• Social inequality in cancer survivorship: Educational differences in health‐related quality of life among 27,857 cancer survivors in Denmark (2023 · Cancer Medicine · 被引 24)
• Risk of Venous Thromboembolism in Patients With Stage III and IV Non–Small-Cell Lung Cancer: Nationwide Descriptive Cohort Study (2024 · Clinical Lung Cancer · 被引 20)
• Time Toxicity of Systemic Anticancer Therapy for Metastatic Lung Cancer in Routine Clinical Practice: A Nationwide Cohort Study (2024 · JCO Oncology Practice · 被引 18)